ARCA BIOPHARMA ANNOUNCES THIRD QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Posted on November 6, 2019 by ARCA IT - Press Release, Uncategorized ARCA-3Q19-Financial-Results-and-Business-Update
HFSA 2019 Poster – GENETIC-AF LVEF Data Posted on September 13, 2019 by ARCA IT - Uncategorized GAF-LVEF-poster-for-HFSA-2019
ARCA BIOPHARMA PRESIDENT AND CEO DR. MICHAEL BRISTOW TO PRESENT AT HFSA 2019 EXCELLENCE IN TRANSLATIONAL SCIENCE SYMPOSIUM Posted on September 12, 2019 by ARCA IT - Press Release, Uncategorized HFSA-2019-Symposium-Dr-Bristow-Presentation
ARCA BIOPHARMA ANNOUNCES GENCARO ATRIAL FIBRILLATION CLINICAL DATA SELECTED FOR PRESENTATION AT HFSA 2019 SCIENTIFIC MEETING Posted on September 11, 2019 by ARCA IT - Press Release, Uncategorized HFSA-2019-Poster-GENETIC-AF-Data
ARCA BIOPHARMA ANNOUNCES SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Posted on August 1, 2019 by ARCA IT - Press Release, Uncategorized ARCA - 2Q19 Financial Results and Business Update
ARCA BIOPHARMA ANNOUNCES SUBMISSION OF PATENT APPLICATON TO U.S. PATENT AND TRADEMARK OFFICE COVERING TREATMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH HEART FAILURE Posted on May 13, 2019 by ARCA IT - Press Release, Uncategorized Gencaro AF HF Patent Submission 2019
ARCA BIOPHARMA ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Posted on May 8, 2019 by ARCA IT - Press Release, Uncategorized ARCA - 1Q19 Financial Results and Business Update
GENETIC-AF PHASE 2B TRIAL RESULTS PUBLISHED IN THE JOURNAL OF AMERICAN COLLEGE OF CARDIOLOGY: HEART FAILURE Posted on May 1, 2019 by ARCA IT - Press Release, Uncategorized GENETIC-AF Data - JACC April 2019
ARCA BIOPHARMA ANNOUNCES STEERING COMMITTEE OF LEADING INTERNATIONAL CARDIOLOGY AND ELECTROPHYSIOLOGY EXPERTS FOR PRECISION-AF PHASE 3 CLINICAL TRIAL Posted on April 23, 2019 by ARCA IT - Press Release, Uncategorized PRECISION-AF Steering Committee - FINAL
IDENTIFICATION OF PHOSPHODIESTEREASE 3A POLYMORPHISM WITH POTENTIAL TO INCREASE EFFECTIVENESS OF PDE3 INHIBITORS PUBLISHED IN THE JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Posted on March 18, 2019 by ARCA IT - Press Release, Uncategorized PDE3A PMx JACC - FINAL